Merck Debt to Equity Ratio 2006-2018 | MRK

Current and historical debt to equity ratio values for Merck (MRK) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $92.237B $40.122B
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $334.531B 16.56
Pfizer (PFE) United States $222.518B 13.69
Novartis AG (NVS) Switzerland $182.129B 15.78
AbbVie (ABBV) United States $152.737B 15.57
Novo Nordisk (NVO) Denmark $121.004B 20.05
Sanofi (SNY) France $104.713B 13.25
GlaxoSmithKline (GSK) United Kingdom $102.153B 13.97
Eli Lilly (LLY) United States $96.679B 19.20
AstraZeneca (AZN) United Kingdom $92.856B 9.72
Bristol-Myers Squibb (BMY) United States $92.237B 18.15